I

ImmunityBio

Organization

Heard in 4 episodes across 1 show since Mar 2026

ImmunityBio is a biotechnology company developing immunotherapies and vaccines for cancer and infectious diseases.

Email alerts

Episodes

4
across 1 show

First heard

Mar 2026

Expert statements

6
2 positive · 1 negative

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Nov 20250
Dec 20250
Jan 20260
Feb 20260
Mar 20262
Apr 20261
May 20260
Jun 20261
Jul 20260
Aug 20260
Sep 20260
Oct 20260

Email alert

Email me when ImmunityBio comes up on a podcast

One email a week at most, with the new episodes that mention ImmunityBio. Free, no account needed, unsubscribe in one click.

What experts have said about ImmunityBio

6 statements · 2 positive · 1 negative · 2 mixed · 1 neutral

  1. Jim CramerPositiveOct 26, 2026· Mad Money w/ Jim Cramer

    ImmunityBio is a strong speculative investment.

    “That is a situation that's a very good spec.”

    Listen at 36:39

    Open the episode · Mad Money w/ Jim Cramer 10/26/26
  2. Jim CramerPositiveOct 26, 2026· Mad Money w/ Jim Cramer

    Investors may take a position in ImmunityBio now.

    “I don't mind you take a position now”

    Listen at 36:42

    Open the episode · Mad Money w/ Jim Cramer 10/26/26
  3. Jim CramerMixedJun 16, 2026· Mad Money w/ Jim Cramer

    Investors may use ImmunityBio as their single speculative position.

    “Let Immunity Bio be your speculation.”

    Listen at 38:04

    Open the episode · Mad Money w/ Jim Cramer 6/16/26
See all 6 statements →

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

4 episodes featuring ImmunityBio, newest first